{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T17:40:36Z","timestamp":1794678036809,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00456616"],"award-info":[{"award-number":["RS-2024-00456616"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-00520453"],"award-info":[{"award-number":["RS-2025-00520453"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-0045661"],"award-info":[{"award-number":["RS-2024-0045661"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gyeongsangbuk-do RISE","award":["2025-RISE-15-107"],"award-info":[{"award-number":["2025-RISE-15-107"]}]},{"DOI":"10.13039\/501100010418","name":"Institute for Information and Communications Technology Promotion","doi-asserted-by":"publisher","award":["RS-2024-00459749"],"award-info":[{"award-number":["RS-2024-00459749"]}],"id":[{"id":"10.13039\/501100010418","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Synthetic cannabinoid receptor agonists constitute a prominent class of new psychoactive substances (NPS), in which minor structural modifications can markedly influence in vivo pharmacological outcomes. In this study, methoxy-substituted derivatives of\n                    <jats:bold>JWH-018<\/jats:bold>\n                    were synthesized to examine the effect of substitution position on behavioral activity.\n                    <jats:bold>JWH-018\u20135-OMe<\/jats:bold>\n                    and\n                    <jats:bold>JWH-018\u20136-OMe<\/jats:bold>\n                    were evaluated using four in vivo assays, including catalepsy, hypothermia, analgesia, and locomotor activity. JWH-018\u20135-OMe selectively reduced rectal temperature, with limited effects observed in catalepsy, analgesia, and locomotor activity. Notably,\n                    <jats:bold>JWH-018\u20136-OMe<\/jats:bold>\n                    elicited robust and dose-dependent effects across all four behavioral endpoints, closely resembling the pharmacological profile of the parent compound,\n                    <jats:bold>JWH-018<\/jats:bold>\n                    . Collectively, these results demonstrate that structural variations on the indole scaffold can produce measurable psychoactive effects, underscoring the importance of continued evaluation of indole-based synthetic cannabinoids within the NPS framework.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-51639-z","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:04:50Z","timestamp":1778504690000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["In vivo evaluation of synthetic cannabinoid JWH-018 derivatives as potential new psychoactive substances"],"prefix":"10.1038","volume":"16","author":[{"given":"Salman","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minseo","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Hoon","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Soo","family":"Myeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"51639_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s40199-025-00572-z","volume":"33","author":"I-M Marandiuc","year":"2025","unstructured":"Marandiuc, I.-M. et al. New psychoactive substances: A multidisciplinary review of challenges and their diverse character. DARU J. Pharm. Sci. 33, 29 (2025).","journal-title":"DARU J. Pharm. Sci."},{"key":"51639_CR2","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/S0140-6736(19)32231-7","volume":"394","author":"A Peacock","year":"2019","unstructured":"Peacock, A. et al. New psychoactive substances: Challenges for drug surveillance, control, and public health responses. Lancet 394, 1668\u20131684 (2019).","journal-title":"Lancet"},{"key":"51639_CR3","doi-asserted-by":"publisher","first-page":"E116","DOI":"10.1093\/jat\/bkac023","volume":"46","author":"AL Mohr","year":"2022","unstructured":"Mohr, A. L. et al. Reports of adverse events associated with use of novel psychoactive substances, 2017\u20132020: A review. J. Anal. Toxicol. 46, E116\u2013E185 (2022).","journal-title":"J. Anal. Toxicol."},{"key":"51639_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2011.00060","volume":"5","author":"L Fattore","year":"2011","unstructured":"Fattore, L. & Fratta, W. Beyond THC: The new generation of cannabinoid designer drugs. Front. Behav. Neurosci. 5, 60 (2011).","journal-title":"Front. Behav. Neurosci."},{"key":"51639_CR5","first-page":"618","volume":"64","author":"R Law","year":"2015","unstructured":"Law, R. et al. Notes from the field: Increase in reported adverse health effects related to synthetic cannabinoid use\u2014United States, January\u2013May 2015. MMWR. Morb. Mortal. Wkly. Rep. 64, 618\u2013619 (2015).","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"51639_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pbb.2014.05.010","volume":"124","author":"R Marshell","year":"2014","unstructured":"Marshell, R. et al. In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid \u03949-THC in mice: Inhalation versus intraperitoneal injection. Pharmacol. Biochem. Behav. 124, 40\u201347 (2014).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"51639_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.etdah.2022.100044","volume":"2","author":"J Neicun","year":"2022","unstructured":"Neicun, J., Roman-Urrestarazu, A. & Czabanowska, K. Legal responses to novel psychoactive substances implemented by ten European countries: An analysis from legal epidemiology. Emerg. Trends Drugs Addict. Health. 2, 100044 (2022).","journal-title":"Emerg. Trends Drugs Addict. Health."},{"key":"51639_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2023.105338","volume":"138","author":"OA Lin","year":"2023","unstructured":"Lin, O. A., Chuang, P.-J. & Tseng, Y. J. Comparison of controlled drugs and new psychoactive substances (NPS) regulations in East and Southeast Asia. Regul. Toxicol. Pharmacol. 138, 105338 (2023).","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"51639_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.forsciint.2009.06.008","volume":"191","author":"R Lindigkeit","year":"2009","unstructured":"Lindigkeit, R. et al. Spice: A never ending story?. Forensic Sci. Int. 191, 58\u201363 (2009).","journal-title":"Forensic Sci. Int."},{"key":"51639_CR10","unstructured":"National Forensic Service. Drug Analysis White Paper 2024. (National Forensic Service, 2024)."},{"key":"51639_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1146\/annurev-pharmtox-031122-113758","volume":"63","author":"R Roque-Bravo","year":"2023","unstructured":"Roque-Bravo, R. et al. Synthetic cannabinoids: A pharmacological and toxicological overview. Annu. Rev. Pharmacol. Toxicol. 63, 187\u2013209 (2023).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"51639_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/15563650.2019.1661425","volume":"58","author":"A Potts","year":"2020","unstructured":"Potts, A., Cano, C., Thomas, S. & Hill, S. Synthetic cannabinoid receptor agonists: Classification and nomenclature. Clin. Toxicol. 58, 82\u201398 (2020).","journal-title":"Clin. Toxicol."},{"key":"51639_CR13","doi-asserted-by":"publisher","first-page":"E21917","DOI":"10.1371\/journal.pone.0021917","volume":"6","author":"LK Brents","year":"2011","unstructured":"Brents, L. K. et al. Phase I hydroxylated metabolites of the K2 synthetic cannabinoid Jwh-018 retain in vitro and in vivo Cannabinoid 1 Receptor affinity and activity. PLoS One 6, E21917 (2011).","journal-title":"PLoS One"},{"key":"51639_CR14","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1124\/dmd.112.047530","volume":"40","author":"KC Chimalakonda","year":"2012","unstructured":"Chimalakonda, K. C. et al. Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2\/Spice: Identification of novel cannabinoid receptor ligands. Drug Metab. Dispos. 40, 2174\u20132184 (2012).","journal-title":"Drug Metab. Dispos."},{"key":"51639_CR15","doi-asserted-by":"publisher","first-page":"9.59. 51","DOI":"10.1002\/cpns.31","volume":"80","author":"M Metna\u2010Laurent","year":"2017","unstructured":"Metna\u2010Laurent, M., Mond\u00e9sir, M., Grel, A., Vall\u00e9e, M. & Piazza, P. V. Cannabinoid\u2010induced tetrad in mice. Curr. Protoc. Neurosci. 80, 9.59. 51-59.59. 10 (2017).","journal-title":"Curr. Protoc. Neurosci."},{"key":"51639_CR16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jep.2009.08.026","volume":"126","author":"AT El-Alfy","year":"2009","unstructured":"El-Alfy, A. T., Wilson, L., Elsohly, M. A. & Abourashed, E. A. Towards a better understanding of the psychopharmacology of nutmeg: Activities in the mouse tetrad assay. J. Ethnopharmacol. 126, 280\u2013286 (2009).","journal-title":"J. Ethnopharmacol."},{"key":"51639_CR17","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1111\/bph.14958","volume":"177","author":"XF Wang","year":"2020","unstructured":"Wang, X. F. et al. Different receptor mechanisms underlying phytocannabinoid\u2010versus synthetic cannabinoid\u2010induced tetrad effects: Opposite roles of Cb1\/Cb2 versus Gpr55 receptors. Br. J. Pharmacol. 177, 1865\u20131880 (2020).","journal-title":"Br. J. Pharmacol."},{"key":"51639_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00216-011-4931-5","volume":"401","author":"S Beuck","year":"2011","unstructured":"Beuck, S. et al. Structure characterisation of urinary metabolites of the cannabimimetic Jwh-018 using chemically synthesised reference material for the support of Lc-Ms\/Ms-based drug testing. Anal. Bioanal. Chem. 401, 493\u2013505 (2011).","journal-title":"Anal. Bioanal. Chem."},{"key":"51639_CR19","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1021\/acschemneuro.2c00160","volume":"13","author":"DA Rodriguez-Soacha","year":"2022","unstructured":"Rodriguez-Soacha, D. A. et al. Development of an indole-amide-based photoswitchable cannabinoid receptor subtype 1 (Cb1r) \u201ccis-on\u201d agonist. ACS Chem. Neurosci. 13, 2410\u20132435 (2022).","journal-title":"ACS Chem. Neurosci."},{"key":"51639_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00703","volume":"12","author":"L Uttl","year":"2018","unstructured":"Uttl, L. et al. Behavioral and pharmacokinetic profile of indole-derived synthetic cannabinoids Jwh-073 and Jwh-210 as compared to the phytocannabinoid \u03949-Thc in rats. Front. Neurosci. 12, 703 (2018).","journal-title":"Front. Neurosci."},{"key":"51639_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2012.00110","volume":"3","author":"T Morera-Herreras","year":"2012","unstructured":"Morera-Herreras, T., Miguelez, C., Aristieta, A., Ruiz-Ortega, J. \u00c1. & Ugedo, L. Endocannabinoid modulation of dopaminergic motor circuits. Front. Pharmacol. 3, 110 (2012).","journal-title":"Front. Pharmacol."},{"key":"51639_CR22","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1111\/bph.13215","volume":"173","author":"C Garc\u00eda","year":"2016","unstructured":"Garc\u00eda, C., Palomo-Garo, C., G\u00f3mez-G\u00e1lvez, Y. & Fern\u00e1ndez-Ruiz, J. Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia. Br. J. Pharmacol. 173, 2069\u20132079 (2016).","journal-title":"Br. J. Pharmacol."},{"key":"51639_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neuint.2007.07.014","volume":"52","author":"Z Sidl\u00f3","year":"2008","unstructured":"Sidl\u00f3, Z., Reggio, P. H. & Rice, M. E. Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H2O2, and KATP channels. Neurochem. Int. 52, 80\u201388 (2008).","journal-title":"Neurochem. Int."},{"key":"51639_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1476-5381.2009.00582.x","volume":"160","author":"BK Atwood","year":"2010","unstructured":"Atwood, B. K., Huffman, J., Straiker, A. & Mackie, K. JWH018, a common constituent of \u2018Spice\u2019herbal blends, is a potent and efficacious cannabinoid CB1 receptor agonist. Br. J. Pharmacol. 160, 585\u2013593 (2010).","journal-title":"Br. J. Pharmacol."},{"key":"51639_CR25","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1124\/jpet.301.3.963","volume":"301","author":"SM Rawls","year":"2002","unstructured":"Rawls, S. M., Cabassa, J., Geller, E. B. & Adler, M. W. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4, 5-Dihydro-2-Methyl-4 (4-Morpholinylmethyl)-1-(1-Naphthalenyl-Carbonyl)-6 H-Pyrrolo [3, 2, 1ij] Quinolin-6-One]-induced hypothermia. J. Pharmacol. Exp. Ther. 301, 963\u2013968 (2002).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"51639_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.135021","volume":"732","author":"GC Ripamonte","year":"2020","unstructured":"Ripamonte, G. C. et al. Functional role for preoptic CB1 receptors in breathing and thermal control. Neurosci. Lett. 732, 135021 (2020).","journal-title":"Neurosci. Lett."},{"key":"51639_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.phrs.2015.09.006","volume":"102","author":"S Tai","year":"2015","unstructured":"Tai, S. et al. Repeated administration of phytocannabinoid \u03949-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner. Pharmacol. Res. 102, 22\u201332 (2015).","journal-title":"Pharmacol. Res."},{"key":"51639_CR28","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.neuint.2006.03.015","volume":"49","author":"PK Bonfils","year":"2006","unstructured":"Bonfils, P. K., Reith, J., Hasseldam, H. & Johansen, F. F. Estimation of the hypothermic component in neuroprotection provided by cannabinoids following cerebral ischemia. Neurochem. Int. 49, 508\u2013518 (2006).","journal-title":"Neurochem. Int."},{"key":"51639_CR29","doi-asserted-by":"publisher","first-page":"E40889","DOI":"10.1371\/journal.pone.0040889","volume":"7","author":"N Suzuki","year":"2012","unstructured":"Suzuki, N. et al. Contribution of hypothermia and CB1 receptor activation to protective effects of TAK-937, a cannabinoid receptor agonist, in rat transient MCAO model. PLoS. One 7, E40889 (2012).","journal-title":"PLoS. One"},{"key":"51639_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.lfs.2013.09.017","volume":"97","author":"WE Fantegrossi","year":"2014","unstructured":"Fantegrossi, W. E., Moran, J. H., Radominska-Pandya, A. & Prather, P. L. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to \u03949-THC: Mechanism underlying greater toxicity?. Life Sci. 97, 45\u201354 (2014).","journal-title":"Life Sci."},{"key":"51639_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuroscience.2012.03.038","volume":"213","author":"A Wilson-Poe","year":"2012","unstructured":"Wilson-Poe, A., Morgan, M., Aicher, S. & Hegarty, D. Distribution of CB1 cannabinoid receptors and their relationship with Mu-opioid receptors in the rat periaqueductal gray. Neuroscience 213, 191\u2013200 (2012).","journal-title":"Neuroscience"},{"key":"51639_CR32","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.neuropharm.2008.07.038","volume":"55","author":"AR Wilson","year":"2008","unstructured":"Wilson, A. R., Maher, L. & Morgan, M. M. Repeated cannabinoid injections into the rat periaqueductal gray enhance subsequent morphine antinociception. Neuropharmacology 55, 1219\u20131225 (2008).","journal-title":"Neuropharmacology"},{"key":"51639_CR33","first-page":"2","volume":"3","author":"GX Santos","year":"2020","unstructured":"Santos, G. X. et al. The influence of the cannabinoid receptor Cb1 on the periaqueductal gray in mice treated with photobiomodulation after chronic constriction injury of the sciatic nerve: A placebo-controlled trial. Braz. J. Pain. 3, 2\u20137 (2020).","journal-title":"Braz. J. Pain."},{"key":"51639_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0009-3084(02)00154-8","volume":"121","author":"AG Hohmann","year":"2002","unstructured":"Hohmann, A. G. Spinal and peripheral mechanisms of cannabinoid antinociception: Behavioral, neurophysiological and neuroanatomical perspectives. Chem. Phys. Lipids 121, 173\u2013190 (2002).","journal-title":"Chem. Phys. Lipids"},{"key":"51639_CR35","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1073\/pnas.96.10.5780","volume":"96","author":"A Zimmer","year":"1999","unstructured":"Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M. & Bonner, T. I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid Cb1 receptor knockout mice. Proc. Natl. Acad. Sci. U. S. A. 96, 5780\u20135785 (1999).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"51639_CR36","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s00213-021-05995-5","volume":"239","author":"CF Moore","year":"2022","unstructured":"Moore, C. F. & Weerts, E. M. Cannabinoid tetrad effects of oral \u03949-Tetrahydrocannabinol (Thc) and cannabidiol (Cbd) in male and female rats: Sex, dose-effects and time course evaluations. Psychopharmacology 239, 1397\u20131408 (2022).","journal-title":"Psychopharmacology"},{"key":"51639_CR37","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1021\/jo00408a041","volume":"43","author":"WC Still","year":"1978","unstructured":"Still, W. C., Kahn, M. & Mitra, A. Rapid chromatographic technique for preparative separations with moderate resolution. J. Org. Chem. 43, 2923\u20132925 (1978).","journal-title":"J. Org. Chem."},{"key":"51639_CR38","unstructured":"Makriyannis, A. Cannabimimetic Indole Derivatives. (2005)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51639-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51639-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51639-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:02:10Z","timestamp":1783684930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51639-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51639"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51639-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21528"}}